HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

AbstractBACKGROUND:
The HLA-DRB*1501 haplotype influences the risk of developing multiple sclerosis (MS), but it is not known how it affects grey matter pathology.
AIM:
To assess HLA-DRB(*)1501 effects on magnetic resonance imaging (MRI) cortical grey matter pathology.
METHODS:
Whole and lesional cortical grey matter volumes, lesional and normal-appearing grey matter magnetization transfer ratio were measured in 85 people with MS and 36 healthy control subjects. HLA-DRB(*)1501 haplotype was determined by genotyping (rs3135388).
RESULTS:
No significant differences were observed in MRI measures between the HLA-DRB(*)1501 subgroups.
CONCLUSIONS:
The HLA-DRB(*)1501 haplotype is not strongly associated with MRI-visible grey matter pathology.
AuthorsÖzgür Yaldizli, Varun Sethi, Matteo Pardini, Carmen Tur, Kin Y Mok, Nils Muhlert, Zheng Liu, Rebecca S Samson, Claudia A M Wheeler-Kingshott, Tarek A Yousry, Henry Houlden, John Hardy, David H Miller, Declan T Chard
JournalMultiple sclerosis and related disorders (Mult Scler Relat Disord) Vol. 7 Pg. 47-52 (May 2016) ISSN: 2211-0356 [Electronic] Netherlands
PMID27237756 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • HLA-DRB1 Chains
  • HLA-DRB1*15:01 antigen
Topics
  • Adult
  • Cerebral Cortex (diagnostic imaging)
  • Disability Evaluation
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Gray Matter (diagnostic imaging)
  • HLA-DRB1 Chains (genetics)
  • Haplotypes
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Multiple Sclerosis (diagnostic imaging, genetics)
  • Organ Size
  • Polymorphism, Single Nucleotide
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: